Kaplan-Meier time-to-event estimates in men with hemophilia and HCV infection. (A-D) Kaplan-Meier time-to-event analyses over a 10 000-day time frame, comparing (A) ESLD (red) vs no ESLD (blue) (P < .001); (B) HIV (red) vs no HIV (blue) (P = .001); (C) antiviral therapy (Tx) (red) vs no antiviral therapy (Tx) (blue) (P = .001); and (D) HCC (red) vs no HCC (blue) (P = .027). Survival curves were compared between groups using the log-rank test. The dashed lines represent 95% CIs. The time in days is shown on the x-axis, and the survival probability is shown on the y-axis.